Literature DB >> 15474288

Cell targeted phagemid rescued by preselected landscape phage.

Jane D Mount1, Tatiana I Samoylova, Nancy E Morrison, Nancy R Cox, Henry J Baker, Valery A Petrenko.   

Abstract

We have developed a gene delivery system that utilizes a cell-binding helper phage preselected from a landscape phage display library, and a phagemid harboring a marker gene and all regulatory elements (origins of replication and promoter-enhancer cassettes) necessary for replication of the phagemid and expression of the marker gene in the targeted cell. All the proteins required for encapsulation of the phagemid DNA and cell targeting are provided by the phage helper and are separate from the phagemid. Therefore, the resultant Phagemid Infective Particles (PIPs) are able to bind and infect target cells and express the marker gene from within the cell. Our approach, shown here for glioma cells, differs from others in that a phagemid expressing a model marker or particular therapeutic gene can be easily exchanged for a phagemid expressing a different therapeutic gene. Also, a different helper phage, selected from a phage display library, such as the f8-8-mer landscape library used here, can target any cell type and direct the encapsulation of any therapeutic gene encoding phagemid. Because of its versatility, the PIPs system may be readily used for optimization of the gene-delivery strategies applied to specific cell and tissue targets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474288     DOI: 10.1016/j.gene.2004.07.006

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  20 in total

1.  Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.

Authors:  Ana Maria Gonzalez; Wendy Leadbeater; Sonia Podvin; Alexandra Borboa; Michael Burg; Ritsuko Sawada; James Rayner; Karen Sims; Tetsuya Terasaki; Conrad Johanson; Edward Stopa; Brian Eliceiri; Andrew Baird
Journal:  Brain Res       Date:  2010-08-21       Impact factor: 3.252

2.  Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization.

Authors:  Gopal Abbineni; Sita Modali; Barbara Safiejko-Mroczka; Valery A Petrenko; Chuanbin Mao
Journal:  Mol Pharm       Date:  2010-08-25       Impact factor: 4.939

3.  Landscape Phage as a Molecular Recognition Interface for Detection Devices.

Authors:  Valery A Petrenko
Journal:  Microelectronics J       Date:  2008-02

Review 4.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

5.  Gene transfer into Mammalian cells using targeted filamentous bacteriophage.

Authors:  Andrew Baird
Journal:  Cold Spring Harb Protoc       Date:  2011-08-01

6.  Selection of Lung Cancer-Specific Landscape Phage for Targeted Drug Delivery.

Authors:  James W Gillespie; Lixia Wei; Valery A Petrenko
Journal:  Comb Chem High Throughput Screen       Date:  2016       Impact factor: 1.339

Review 7.  Phage protein-targeted cancer nanomedicines.

Authors:  V A Petrenko; P K Jayanna
Journal:  FEBS Lett       Date:  2013-11-20       Impact factor: 4.124

8.  Promiscuous tumor targeting phage proteins.

Authors:  Amanda L Gross; James W Gillespie; Valery A Petrenko
Journal:  Protein Eng Des Sel       Date:  2016-01-12       Impact factor: 1.650

9.  DeltaPhage--a novel helper phage for high-valence pIX phagemid display.

Authors:  Nicolay R Nilssen; Terje Frigstad; Sylvie Pollmann; Norbert Roos; Bjarne Bogen; Inger Sandlie; Geir Å Løset
Journal:  Nucleic Acids Res       Date:  2012-04-26       Impact factor: 16.971

10.  Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system.

Authors:  Ana Maria Gonzalez; Wendy E Leadbeater; Michael Burg; Karen Sims; Tetsuya Terasaki; Conrad E Johanson; Edward G Stopa; Brian P Eliceiri; Andrew Baird
Journal:  BMC Neurosci       Date:  2011-01-07       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.